Europe
-
-
-
The UK is still struggling with stubbornly high inflation and interest rates at 5.25% -
The Finnish biopharmaceutical company tapped shareholders for capital on Thursday night
-
No Pepp talk from Lagarde relieves market participants but issuance could face ‘headwind into next year’
-
Relieved market enjoys a rally, but weaker names are still out of favour
-
Despite rush of agency deals in dollars, pinpointing fair value is hard
-
Sponsors may have to list portfolio companies whether they like the price or not
-
Traditional finance turns its back on the sector as mass ratings downgrades loom
-
The former FIG dealmaker has landed his first acquisition but growth ambitions for the investment bank remain on the mid-market
-
Tumbling sentiment and red flags for the eurozone economy to slam end of year activity
-
Sale took place on volatile day but big book saw it through
